This page shows prior authorization criteria extracted from UnitedHealthcare's published imaging guidelines. 115 matching coverage rules found for this procedure.
Abdominal Pain
Indication Code: AB-2.2
Abdominal Sepsis/Abscess
Indication Code: AB-3.1
Abdominal Ultrasound
Indication Code: AB-1.6
Abdominal Wall Mass
Indication Code: PEDAB-13.1
Abdominal Wall Mass
Indication Code: AB-13.1
Abnormal Liver Chemistries
Indication Code: AB-30.1
Acute Lymphoblastic Leukemia (ALL)
Indication Code: PEDONC-3.2
Acute Pancreatitis
Indication Code: PEDAB-34.1
Acute Pancreatitis
Indication Code: AB-33.1
Adrenal Lesions
Indication Code: PEDAB-17
Adrenal Lesions
Indication Code: PEDAB-17
Annual Surveillance
Indication Code: AB-4.4
Ascites
Indication Code: AB-26.2
Atypical Teratoid/Rhabdoid Tumors (ATRT)
Indication Code: PEDONC-4.5
Beckwith-Wiedemann Syndrome (BWS)
Indication Code: PEDONC-2.4
Bilateral Wilms Tumor (BWT)
Indication Code: PEDONC-7.3
Biliary Disease
Indication Code: PEDAB-16.2
Blunt Abdominal Trauma
Indication Code: AB-10.1
Cardiac Imaging in Transplants
Indication Code: CD-16
Chronic Liver Disease, Cirrhosis and Screening for HCC
Indication Code: AB-26.1
Chronic Pancreatitis
Indication Code: PEDAB-34.2
Chronic Pancreatitis
Indication Code: AB-33.2
Classical Hodgkin Lymphoma
Indication Code: ONC-28.2
Clear Cell Sarcoma of the Kidney (CCSK)
Indication Code: PEDONC-7.5
Costello Syndrome
Indication Code: PEDONC-2.14
Denys-Drash Syndrome (DDS)
Indication Code: PEDONC-2.5
Familial Adenomatous Polyposis (FAP) and Related Conditions
Indication Code: PEDONC-2.7
Fever of Unknown Origin (FUO)
Indication Code: ONC-30.1
Flank Pain, Renal Stone
Indication Code: PEDAB-4
Flank Pain, Renal Stone
Indication Code: PEDAB-4
Follow-Up of Treated Renal/Ureteral Stone
Indication Code: AB-4.3
General Considerations for Stem Cell Transplant
Indication Code: ONC-29.1
Generalized Abdominal Pain
Indication Code: PEDAB-2
Generalized Abdominal Pain
Indication Code: PEDAB-2
Hematuria
Indication Code: PEDAB-7
Hematuria
Indication Code: PEDAB-7
Hemophagocytic Lymphohistiocytosis (HLH)
Indication Code: PEDONC-18.3
Hepatic Arteries and Veins
Indication Code: AB-43.1
Hydrocephalus Shunts
Indication Code: HD-11.14
Hydrocephalus, Shunts, and Endoscopic Third Ventriculostomy (ETV)
Indication Code: PEDHD-7.3
Hydronephrosis
Indication Code: PEDAB-20
Hydronephrosis
Indication Code: PEDAB-20
Hydronephrosis of Unexplained or Indeterminate Cause
Indication Code: AB-39.4
Indeterminate Intra-Abdominal Mass
Indication Code: AB-13.2
Intra-Abdominal Mass
Indication Code: PEDAB-13.2
Intussusception
Indication Code: PEDAB-27
Intussusception
Indication Code: PEDAB-27
Isolated or Incidental Hepatomegaly
Indication Code: AB-29.4
Kidney Transplant, Post-Transplant
Indication Code: AB-42.6
Langerhans Cell Histiocytosis (LCH)
Indication Code: PEDONC-18.2
Li-Fraumeni Syndrome (LFS)
Indication Code: PEDONC-2.2
Liver Lesion Characterization
Indication Code: PEDAB-15
Liver Lesion Characterization
Indication Code: PEDAB-15
Liver Transplant, Post-Transplant Imaging
Indication Code: AB-42.3
Liver Transplant, Pre-Transplant
Indication Code: AB-42.1
Lower Extremity Artery Aneurysms
Indication Code: PVD-7.4
Lower Urinary Tract
Indication Code: PEDAB-5.2
LUMBAR Syndrome
Indication Code: PEDPVD-5.4
Malignant Rhabdoid Tumor of the Kidney (MRT) and Other Extracranial Sites
Indication Code: PEDONC-7.6
Melanoma – Surveillance/Follow-up
Indication Code: ONC-5.4
Monitoring After Fontan Procedure
Indication Code: AB-26.4
Multiple Endocrine Neoplasias (MEN)
Indication Code: PEDONC-2.8
Multiple Infantile Hemangiomas
Indication Code: PEDPVD-5.2
Observation of Known Renal/Ureteral Stone(s)
Indication Code: AB-4.2
Other Renal Cell Cancer Predisposition Syndromes
Indication Code: PEDONC-2.17
Pancreatic Cancer – Suspected/Diagnosis
Indication Code: ONC-13.2
Patent Urachus
Indication Code: PV-23.1
Pediatric Aggressive Mature B-Cell Non-Hodgkin Lymphomas (NHL)
Indication Code: PEDONC-5.3
Pediatric Liver Failure and Cirrhosis
Indication Code: PEDAB-16.1
Pelvic Pain/Dyspareunia, Female
Indication Code: PV-11.1
Polycystic Kidney Disease
Indication Code: PEDAB-21
Polycystic Kidney Disease
Indication Code: PEDAB-21
Polycystic Kidney Disease
Indication Code: AB-38.1
Portal Hypertension
Indication Code: AB-26.3
Post-Transplant Imaging
Indication Code: PEDONC-20.2
Postoperative Pain within 60 Days Following Abdominal Surgery
Indication Code: PEDAB-11
Postoperative Pain within 60 Days Following Abdominal Surgery
Indication Code: PEDAB-11
Pre-Transplant Imaging
Indication Code: PEDONC-20.1
Primary Sclerosing Cholangitis (PSC)
Indication Code: AB-23.4
Pyelonephritis
Indication Code: AB-40.1
Renal Failure
Indication Code: AB-36.1
Renovascular Hypertension and Other Secondary Causes of Hypertension
Indication Code: PEDAB-14
Renovascular Hypertension and Other Secondary Causes of Hypertension
Indication Code: PEDAB-14
Renovascular Hypertension/Renal Artery Stenosis
Indication Code: PVD-6.6
Retroperitoneal Fibrosis
Indication Code: AB-47.0
Retroperitoneal Ultrasound
Indication Code: AB-1.7
Rhabdoid Tumor Predisposition Syndrome
Indication Code: PEDONC-2.11
Right Lower Quadrant Pain
Indication Code: PEDAB-3
Right Lower Quadrant Pain
Indication Code: PEDAB-3
Right Upper Quadrant and Epigastric Pain
Indication Code: AB-2.3
Right Upper Quadrant Pain
Indication Code: PEDAB-8
Right Upper Quadrant Pain
Indication Code: PEDAB-8
Scoliosis
Indication Code: PEDSP-3.2
Screening for Vascular related genetic connective tissue Disorders
Indication Code: PVD-2.2
Small Vessel Vasculitis
Indication Code: PEDPVD-3.4
Small Vessel Vasculitis
Indication Code: PVD-6.11
Spleen
Indication Code: AB-34.1
Splenic Trauma
Indication Code: AB-34.2
Suspected Physical Child Abuse
Indication Code: PEDMS-7
Suspected Renal/Ureteral Stone(s)
Indication Code: AB-4.1
Transitional Cell Cancer – Initial Work-up/Staging
Indication Code: ONC-18.2
Tuberous Sclerosis Complex (TSC)
Indication Code: PEDONC-2.9
Ultrasound
Indication Code: AB-4.0
Unexplained Weight Loss
Indication Code: ONC-30.2
Unilateral Wilms Tumor (UWT)
Indication Code: PEDONC-7.2
Upper Urinary Tract
Indication Code: PEDAB-5.1
Ureteral and/or Bladder Trauma or Injury
Indication Code: PV-25.1
Urinary Incontinence – Initial Imaging
Indication Code: PV-22.1
Uterine Anomalies
Indication Code: PV-14.1
Visceral Artery Aneurysm
Indication Code: PVD-6.5
Visceral Artery Aneurysms
Indication Code: PEDPVD-4.3
Vomiting Infant, Malrotation, and Hypertrophic Pyloric Stenosis
Indication Code: PEDAB-33
Vomiting Infant, Malrotation, and Hypertrophic Pyloric Stenosis
Indication Code: PEDAB-33
Von Hippel-Lindau Syndrome (VHL)
Indication Code: PEDONC-2.10
Wilms Tumor-Aniridia-Growth Retardation (WAGR)
Indication Code: PEDONC-2.6
Standard prior authorization requests are typically processed within 3–5 business days. Urgent/expedited requests may be processed within 24–72 hours when clinically necessary.
Most plans allow 30–60 days to file a first-level appeal. Expedited appeals for urgent cases are typically processed within 72 hours.